Israel Pharmaceuticals & Healthcare Report Q2 2018

Israel Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

Israel will continue to present an attractive opportunity for the sale of patented high-value medicines, with the expansionof the country's health basket set to include additional innovative treatments in 2018. It was announced in December 2017 thatIsrael's basket of health services will be expanded by ILS430mn (USD137mn) in 2018, with over 106 new drugs being added to thegovernment-subsidised list. This corresponds to a similar medicine budget as allocated in 2017 and highlights the Israeligovernment's ongoing commitment to improving patients' access to more 'lifesaving treatments', particularly focusing on theaffordability of diabetes, oncology and rare disease treatments.

BMI Industry View
Industry Forecast
Pharmaceuticals Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
MENA Pharmaceuticals: Diverse Risk/Reward Environment For Patented Drugmakers
Regulatory Review
Regulatory Development
Market Overview
Competitive Landscape
Company Profile
Dexcel Pharma
Neopharm Group
Perrigo (Agis Industries)
Taro Pharmaceutical Industries
Teva Pharmaceutical Industries
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook